Concerns about the long-term safety of live kidney donors are justified

[1]  A. Matas,et al.  Long‐Term Non–End‐Stage Renal Disease Risks After Living Kidney Donation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  A. Hofman,et al.  Live kidney donation: are concerns about long-term safety justified?—A methodological review , 2016, European Journal of Epidemiology.

[3]  A. Israni,et al.  A prospective controlled study of living kidney donors: three-year follow-up. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  M. Woodward,et al.  Kidney measures beyond traditional risk factors for cardiovascular prediction: A collaborative meta-analysis , 2015, The lancet. Diabetes & endocrinology.

[5]  B. Kiberd,et al.  Kidney donation and risk of ESRD. , 2014, JAMA.

[6]  A. Garg,et al.  End-stage renal disease in living kidney donors. , 2014, Kidney international.

[7]  F. Dekker,et al.  Long-term risks for kidney donors. , 2014, Kidney international.

[8]  J. Coresh,et al.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.

[9]  M. Tonelli,et al.  Understanding rare adverse outcomes following living kidney donation. , 2014, JAMA.

[10]  Mei-Cheng Wang,et al.  Risk of end-stage renal disease following live kidney donation. , 2014, JAMA.

[11]  Sonia M. Thomas,et al.  Cardiovascular disease in kidney donors: matched cohort study , 2012, BMJ : British Medical Journal.

[12]  C. Young,et al.  Ethnic and Gender Related Differences in the Risk of End‐Stage Renal Disease After Living Kidney Donation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  L. Bostad,et al.  Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  B. Caffo,et al.  Perioperative mortality and long-term survival following live kidney donation. , 2010, JAMA.

[15]  R. Foley,et al.  Long-term consequences of kidney donation. , 2009, The New England journal of medicine.

[16]  W. Braun,et al.  The science of Stewardship: due diligence for kidney donors and kidney function in living kidney donation--evaluation, determinants, and implications for outcomes. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[17]  T. Leivestad,et al.  Preeclampsia and the risk of end-stage renal disease. , 2008, The New England journal of medicine.

[18]  J. Coresh,et al.  Estimated Glomerular Filtration Rate , 2007 .

[19]  L. Mjörnstedt,et al.  Incidence of End-Stage Renal Disease Among Live Kidney Donors , 2006, Transplantation.

[20]  F. Delmonico.  A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines , 2005, Transplantation.

[21]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.

[22]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[23]  V. Papalois,et al.  Laparoscopic Live Donor Nephrectomy: A Step Forward in Kidney Transplantation? , 2003, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

[24]  L R Kavoussi,et al.  Laparoscopic live donor nephrectomy. , 1999, The Urologic clinics of North America.

[25]  B. Freedman,et al.  Familial risk, age at onset, and cause of end-stage renal disease in white Americans. , 1995, Journal of the American Society of Nephrology : JASN.

[26]  B. Freedman,et al.  The familial risk of end-stage renal disease in African Americans. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  B. Brenner,et al.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. , 1981, The American journal of physiology.

[28]  A. Hartmann,et al.  Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  Z. Ulger,et al.  Gestational hypertension and preeclampsia in living kidney donors. , 2015, The New England journal of medicine.